cell avidity as a predictor of t-cell efficacy
Published 2 years ago • 250 plays • Length 2:41Download video MP4
Download video MP3
Similar videos
-
1:31
eha 2023 t-cell lymphoma highlights
-
2:43
the management of advanced phase mpns
-
1:52
esh cml session highlights: pediatrics, biomarkers, and covid
-
0:41
ash 2021 highlights in cml
-
5:35
clinical and prognostic significance of aberrant t-cell marker expression in aml
-
25:47
[nataliya prokhnevska] cd8 t cell activation in cancer
-
7:28
the 4th iconelt 2024_presentation video
-
43:42
easl studio - s2 e17 - easl haemochromatosis guidelines 2022
-
1:13
the importance of improving the management of cardiotoxicity when treating cll
-
2:00
the development of anti-fibrotic agents for treating myelofibrosis
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
1:12
insights into the optimal management of cll: the importance of patient characteristics
-
1:14
highlights in quality management from ebmt
-
8:57
outcomes of sct in t-all and t-lbl
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
1:53
cll highlights from ash 2023: the flair study
-
1:43
highlights from ebmt 2022
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:30
key topics at esh cml 2022
-
1:03
late effect surveillance following allosct: the publication of new guidelines